W. E. Donoghue & Co »

Alnylam Pharmaceuticals shares owned by W. E. Donoghue & Co

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by W. E. Donoghue & Co from 13F filings

Historical chart of W. E. Donoghue & Co investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by W. E. Donoghue & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by W. E. Donoghue & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.1M 4.6k 456.00

More positions owned by W. E. Donoghue & Co

Spdr Series Trust Bloomberg 1-3 Mo (BIL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Ssga Active Etf Tr Blackstone Senr (SRLN)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Spdr Series Trust Portfli High Yld (SPHY)
BlackRock Floating Rate Income Trust (BGT)
Seagate Technology Hldngs Pl Ord Shs (STX)
Johnson & Johnson (JNJ)
Citigroup Com New (C)
Citizens Financial (CFG)
Altria (MO)
Chevron Corporation (CVX)
Vistra Energy (VST)
Synopsys (SNPS)
Western Digital (WDC)

View all positions for W. E. Donoghue & Co

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals